D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 81 Citations 17,118 202 World Ranking 11599 National Ranking 117

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

Jonathan S.T. Sham focuses on Nasopharyngeal carcinoma, Radiation therapy, Surgery, Carcinoma and Internal medicine. His studies in Nasopharyngeal carcinoma integrate themes in fields like Cisplatin, Survival rate, Immunology, Lymph node and Hazard ratio. His research in Radiation therapy intersects with topics in Stage, Prospective cohort study, Chemotherapy and Nuclear medicine.

His work investigates the relationship between Surgery and topics such as Maxilla that intersect with problems in Masseter muscle, Trismus, Chordoma and Schwannoma. His Carcinoma research incorporates elements of Multivariate analysis, Primary tumor, Tumor marker and Cancer research. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.

His most cited work include:

  • Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. (538 citations)
  • Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group (325 citations)
  • Preliminary report of the asian‐oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma (238 citations)

What are the main themes of his work throughout his whole career to date?

Jonathan S.T. Sham mainly focuses on Nasopharyngeal carcinoma, Carcinoma, Radiation therapy, Surgery and Internal medicine. His Nasopharyngeal carcinoma research is multidisciplinary, incorporating elements of Biopsy, Pathology and Chemotherapy. Within one scientific family, Jonathan S.T. Sham focuses on topics pertaining to Lymph node under Carcinoma, and may sometimes address concerns connected to Lymph.

The study incorporates disciplines such as Stage, Epirubicin, Nuclear medicine and Cisplatin in addition to Radiation therapy. His Surgery study frequently links to adjacent areas such as Neck dissection. His biological study spans a wide range of topics, including Gastroenterology and Oncology.

He most often published in these fields:

  • Nasopharyngeal carcinoma (71.50%)
  • Carcinoma (36.71%)
  • Radiation therapy (34.30%)

What were the highlights of his more recent work (between 2004-2016)?

  • Nasopharyngeal carcinoma (71.50%)
  • Cancer research (15.46%)
  • Radiation therapy (34.30%)

In recent papers he was focusing on the following fields of study:

Jonathan S.T. Sham spends much of his time researching Nasopharyngeal carcinoma, Cancer research, Radiation therapy, Cancer and Internal medicine. His study with Nasopharyngeal carcinoma involves better knowledge in Surgery. His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis, Tumor suppressor gene, Pathology, Metastasis and In vivo.

He interconnects Stage, Scoring system and Nuclear medicine in the investigation of issues within Radiation therapy. His Cancer research includes elements of Psychosocial and Antigen. His work in Internal medicine tackles topics such as Oncology which are related to areas like Survival analysis, Nodal metastasis and Median survival.

Between 2004 and 2016, his most popular works were:

  • Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. (538 citations)
  • Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group (325 citations)
  • Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma (153 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

The scientist’s investigation covers issues in Nasopharyngeal carcinoma, Radiation therapy, Nuclear medicine, Cancer research and Cisplatin. His Nasopharyngeal carcinoma study necessitates a more in-depth grasp of Surgery. His Surgery study which covers Carcinoma that intersects with Gefitinib, Survival analysis and Phases of clinical research.

His Radiation therapy course of study focuses on Stage and Locally advanced, Adjuvant, Clinical trial and Conventional radiotherapy. As part of one scientific family, Jonathan S.T. Sham deals mainly with the area of Nuclear medicine, narrowing it down to issues related to the Radiosurgery, and often Induction chemotherapy, Primary tumor, Ototoxicity, Incidence and Cause of death. His Cancer research study combines topics in areas such as Carcinogenesis, Tumor suppressor gene, Oncogene, Pathology and Anatomical pathology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.

Edmond H.N. Pow;Dora L.W. Kwong;Anne S. McMillan;May C.M. Wong.
International Journal of Radiation Oncology Biology Physics (2006)

870 Citations

Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

Anne W.M. Lee;W.H. Lau;Stewart Y. Tung;Daniel T.T. Chua.
Journal of Clinical Oncology (2005)

535 Citations

Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma

Daniel T. T. Chua;Jonathan S. T. Sham;Damon Choy;Virchan Lorvidhaya.
Cancer (1998)

390 Citations

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.

Dora L.W. Kwong;Jonathan S.T. Sham;Gordon K.H. Au;Daniel T.T. Chua.
Journal of Clinical Oncology (2004)

374 Citations

Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.

Dora L. W. Kwong;Edmond H. N. Pow;Jonathan S. T. Sham;Anne S. McMillan.
Cancer (2004)

320 Citations

Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials

Daniel T.T. Chua;Jun Ma;Jonathan S.T. Sham;Hai Qiang Mai.
Journal of Clinical Oncology (2004)

285 Citations

Association of Vimentin overexpression and hepatocellular carcinoma metastasis

Liang Hu;Sze Hang Lau;Chi Hung Tzang;Jian Ming Wen.
Oncogene (2004)

278 Citations

Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients.

Jonathan S. T. Sham;D. Choy.
British Journal of Radiology (1990)

278 Citations

Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.

D T Chua;J S Sham;D Choy;V Lorvidhaya.
Cancer (1998)

262 Citations

Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy

Daniel T.T Chua;John M Nicholls;Jonathan S.T Sham;Gordon K.H Au.
International Journal of Radiation Oncology Biology Physics (2004)

258 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jonathan S.T. Sham

Xin Yuan Guan

Xin Yuan Guan

University of Hong Kong

Publications: 148

Jun Ma

Jun Ma

Harbin Institute of Technology

Publications: 98

Anthony T.C. Chan

Anthony T.C. Chan

Chinese University of Hong Kong

Publications: 81

Yi Xin Zeng

Yi Xin Zeng

Sun Yat-sen University

Publications: 68

William I. Wei

William I. Wei

University of Hong Kong

Publications: 66

Sai Wah Tsao

Sai Wah Tsao

University of Hong Kong

Publications: 49

Simon Law

Simon Law

University of Hong Kong

Publications: 40

Nancy Y. Lee

Nancy Y. Lee

Memorial Sloan Kettering Cancer Center

Publications: 39

Avraham Eisbruch

Avraham Eisbruch

University of Michigan–Ann Arbor

Publications: 38

Hsiang-Fu Kung

Hsiang-Fu Kung

Chinese University of Hong Kong

Publications: 37

Irene Oi-Lin Ng

Irene Oi-Lin Ng

University of Hong Kong

Publications: 37

Brian O'Sullivan

Brian O'Sullivan

Princess Margaret Cancer Centre

Publications: 33

Xinyuan Liu

Xinyuan Liu

Southern University of Science and Technology

Publications: 27

Johannes A. Langendijk

Johannes A. Langendijk

University Medical Center Groningen

Publications: 27

Jaap M. Middeldorp

Jaap M. Middeldorp

VU University Medical Center

Publications: 27

Adam S. Garden

Adam S. Garden

The University of Texas MD Anderson Cancer Center

Publications: 24

Trending Scientists

Denis Dochain

Denis Dochain

Université Catholique de Louvain

Yong Liang Guan

Yong Liang Guan

Nanyang Technological University

Amitesh Maiti

Amitesh Maiti

Lawrence Livermore National Laboratory

Ernesto Reverchon

Ernesto Reverchon

University of Salerno

Ken McElreavey

Ken McElreavey

Institut Pasteur

P. Hemachandra Reddy

P. Hemachandra Reddy

Texas Tech University Health Sciences Center

Fiona Kumfor

Fiona Kumfor

University of Sydney

Robin Callard

Robin Callard

University College London

Vincent K. Tuohy

Vincent K. Tuohy

Cleveland Clinic Lerner College of Medicine

Margaret J. Wright

Margaret J. Wright

University of Queensland

Stephanie Cacioppo

Stephanie Cacioppo

University of Chicago

Roy G. Brower

Roy G. Brower

Johns Hopkins University

Carmine M. Pariante

Carmine M. Pariante

King's College London

Michael W. Schwartz

Michael W. Schwartz

University of Washington

Ronnie Fass

Ronnie Fass

Case Western Reserve University

Wayne D. Rosamond

Wayne D. Rosamond

University of North Carolina at Chapel Hill

Something went wrong. Please try again later.